Randomised double-blind, placebo-controlled, cross-over study comparing the effects of single dose and repeated dosing treatment for 14 days of vestipitant / paroxetine combination in an enriched population of subjects with tinnitus and hearing loss

Registry ID

EUCTR2006-003295-36

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

GlaxoSmithKline Research & Development Limited

Start date

2006-09-21

Completion date

2009-08-06

Last update

2026-08-16

Conditions

• Tinnitus

Summary

To measure the change in tinnitus loudness (VAS) after single (Day 1) and repeated (Day 14) administration of either vestipitant-paroxetine combination, or vestipitant alone vs. placebo.

Locations

• , , UK

Related clinical trials

• External Therapy for Tinnitus Management
• FR-taVNS Tinnitus Tria
• Manual therapy for the treatment of somatosensory tinnitus aurium – a prospective randomized waitlist-controlled study
• Noninvasive Therapy for Tinnitus
• Acoustic and Electrical Stimulation for the Treatment of Tinnitus
• Evaluating How a Tinnitus Implant Affects Tinnitus Loudness in Adults With Chronic Tinnitus and Varying Levels of Hearing Loss

View on source registry